Company profile

IGEA Pharma N.V. insider transactions

IGEA

Management transactions

1

Shareholding disclosures

42

First disclosure

22.12.2018

Last disclosure

24.10.2023

Company summary

No management purchase or sale disclosed in the last 90 days.

Latest purchase
—

—

Net flow 90 d
CHF 0.00

Buys − sales

Top shareholder
25.15%

Negma Group Ltd

This page brings together all IGEA Pharma N.V. (IGEA) insider transactions: 1 management transactions and 42 significant shareholding disclosures published by SIX Exchange Regulation, from 22.12.2018 to 24.10.2023.

Detailed context

This summary provides an overview of the IGEA Pharma N.V. insider transactions and shareholding reports published by SIX Exchange Regulation. To date, there has been 1 management transaction and 42 significant shareholding disclosures recorded, with the latest management transaction occurring on 2023-10-24. Over the last 90 days, there were 0 purchases (CHF 0) and 0 sales (CHF 0) reported. The largest declared shareholders by voting rights are Negma Group Ltd at 25.15%, followed by ATI Biotech SRL at 9.22%, Blue Sky Angel Lab SRL at 9.22%, and C.H.I. B.V at 9.07%.

Insider barometer

90 days

No transaction in this window

Latest transaction

24.10.2023

Largest purchase

—

Largest sale

CHF 56’700

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Follow IGEA Pharma N.V.’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

IGEA Pharma N.V. insider transactions

Latest shareholding disclosures